These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36939017)

  • 1. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):79-91. PubMed ID: 36939017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hormonal contraceptives for heavy menstrual bleeding.
    Lethaby A; Wise MR; Weterings MA; Bofill Rodriguez M; Brown J
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD000154. PubMed ID: 30742315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
    Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
    Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
    Lepine S; Jo J; Metwally M; Cheong YC
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD; Hunter T; Stuckey B; Hart RJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews.
    Tay CT; Joham AE; Hiam DS; Gadalla MA; Pundir J; Thangaratinam S; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):535-553. PubMed ID: 29846959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives for pain associated with endometriosis.
    Brown J; Crawford TJ; Datta S; Prentice A
    Cochrane Database Syst Rev; 2018 May; 5(5):CD001019. PubMed ID: 29786828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial.
    Moretti C; Guccione L; Di Giacinto P; Simonelli I; Exacoustos C; Toscano V; Motta C; De Leo V; Petraglia F; Lenzi A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):824-838. PubMed ID: 29211888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study.
    Kumarendran B; O'Reilly MW; Subramanian A; Šumilo D; Toulis K; Gokhale KM; Wijeratne CN; Coomarasamy A; Tahrani AA; Azoulay L; Arlt W; Nirantharakumar K
    Diabetes Care; 2021 Dec; 44(12):2758-2766. PubMed ID: 34649997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Norman RJ; Teede HJ
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
    Maier PS; Spritzer PM
    Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.